Sigma Labs (NASDAQ: SGLB), a leading developer of quality
assurance software for the commercial 3D printing industry, today announced
that it will effect a one-for-ten reverse stock split of its outstanding common
stock to regain compliance with the minimum $1.00 bid price per share
requirement of Nasdaq Listing Rule 5550(a)(2). According to the update, Sigma’s
common stock will begin trading on the Nasdaq Capital Market on a split
adjusted basis at market open on Friday, February 28, 2020, and will continue
to trade under the “SGLB” symbol. Following the reverse stock split, the new
CUSIP number for the common stock will be 826598500. The number of common stock
shares that Sigma Labs is authorized to issue will correspondingly decrease
from 22,500,000 to 2,250,000 shares.
To view the full press release, visit http://ibn.fm/LdLm1
About Sigma Labs
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of
quality assurance software to the commercial 3D printing industry under the
PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that
specializes in the development and commercialization of real-time computer
aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced
manufacturing technologies. Sigma Labs’ advanced computer-aided software product
revolutionizes commercial additive manufacturing, enabling non-destructive
quality assurance mid-production, uniquely allowing errors to be corrected in
real-time. For more information, please visit www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates
relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
